Mangalam Drugs And Organics Limited has informed the Exchange regarding Appointment of Mr M/s Ragini Chokshi & Co., as Other of the company w.e.f. September 30, 2025.
MANGALAM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Mangalam Drugs and Organics has appointed Ragini Chokshi & Co., a Practicing Company Secretaries firm (FRN 92897), as its Secretarial Auditors. The appointment was approved by shareholders at the 52nd Annual General Meeting held on September 29, 2025. The firm will serve for a period of five consecutive years, from FY 2025-26 to FY 2029-30, in line with SEBI's Listing Obligations amendment regulations of 2024. Ragini Chokshi & Co. brings over 35 years of experience in legal and secretarial consultancy, serving companies across diversified industries in India and abroad. The disclosure was signed by Chairman and Managing Director Govardhan M. Dhoot.
This is a routine regulatory compliance announcement regarding the appointment of a secretarial auditor, not a change in financial auditors or company leadership. It is unlikely to have any meaningful impact on the stock price or shareholder value.